Q3FY17 results: Thyrocare Technologies Ltd.

Thyrocare Technologies posted its Q3FY17 consolidated results on January 28.

The company's consolidated revenue for the quarter came in at Rs 72 crore, registering a decline of 8.9 per cent quarter on quarter (QOQ). The decline was a result of 10.7 per cent QoQ decrease in its diagnostic testing service business segment revenue.

The firm posted its earnings before interest, tax, depreciation and amortisation (EBITDA) of Rs 27.7 crore as against EBITDA of Rs 30.3 crore posted during the corresponding quarter of the previous year. The net profit of the company came in at Rs 15.4 crore, registering a decline in growth of 23.8 per cent QoQ. This was on the back of 43.4 per cent QoQ drop in the other income.

Thyrocare Technologies Limited is an Indian company incorporated in the year 2000. It helps in setting up hospitals, clinics, diagnosis centre for thyroid disorders and also for teaching and training practical knowledge in diagnostics. For this purpose, it appoints medical and paramedical professionals for conducting diagnosis and therapy in thyrocare and thyroid disorders. The company is based in Maharashtra.